The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Open accessAbstract
The increase of cell surface sialic acid is a characteristic shared by many tumor types. A correlation between hypersialylation and immunoprotection has been observed, but few hypotheses have provided a mechanistic understanding of this immunosuppressive phenomenon. Here, we show that increasing sialylated glycans on cancer cells inhibits human NK cell activation through the recruitment of Siglec-7. Key to these findings was the use of glycopolymers end-functionalized with phospholipids, which enable the introduction of synthetically defined glycans onto cancer cell surfaces. Remodeling the sialylation status of cancer cells affected the susceptibility to NK cell cytotoxicity via Siglec-7 engagement in a variety of tumor types. These results support a model in which hypersialylation offers a selective advantage to tumor cells under pressure from NK immunosurveillance by increasing Siglec ligands. We also exploited this finding to protect allogeneic and xenogeneic primary cells from NK-mediated killing suggesting the potential of Siglecs as therapeutic targets in cell transplant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2056 · Cited by 2,031
Up on the tightrope: natural killer cell activation and inhibition
Lanier, L. L. (2008) · Nature Immunology · doi:10.1038/ni1581 · Cited by 1,656
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863
Targeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses
Naviaux, R. K., Costanzi, E., Haas, M., & Verma, I. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5701-5705.1996 · Cited by 732
Mammalian glycosylation in immunity
Marth, J. D., & Grewal, P. K. (2008) · Nature Reviews Immunology · doi:10.1038/nri2417 · Cited by 712
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Mamessier, E., Sylvain, A., Thibult, M.-L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Gonçalves, A., André, P., Romagné, F., Thibault, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45816 · Cited by 681
Rituximab-Dependent Cytotoxicity by Natural Killer Cells
Dall’Ozzo, S., Tartas, S., Paintaud, G., Cartron, G., Colombat, P., Bardos, P., Watier, H., & Thibault, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2862 · Cited by 434
Biologic and therapeutic role of HER2 in cancer
Ménard, S., Pupa, S. M., Campiglio, M., & Tagliabue, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206779 · Cited by 432
Possible roles of tumor-associated carbohydrate antigens.
Fukuda, M. (1996) · PubMed · Cited by 422
Immunoreceptor tyrosine‐based inhibition motifs: a quest in the past and future
Daëron, M., Jaeger, S., Du Pasquier, L., & Vivier, E. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00666.x · Cited by 370
Cell surface biology mediated by low affinity multivalent protein–glycan interactions
Collins, B. E., & Paulson, J. C. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.10.004 · Cited by 335
Zamai, L., Ponti, C., Mirandola, P., Gobbi, G., Papa, S., Galeotti, L., Cocco, L., & Vitale, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4011 · Cited by 292
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
Terme, M., Ullrich, E., Delahaye, N. F., Chaput, N., & Zitvogel, L. (2008) · Nature Immunology · doi:10.1038/ni1580 · Cited by 289
Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92
Maki, G., Klingemann, H.-G., Martinson, J. A., & Tam, Y. K. (2001) · Journal of Hematotherapy & Stem Cell Research · doi:10.1089/152581601750288975 · Cited by 262
Nicoll, G., Ni, J., Liu, D., Klenerman, P., Munday, J., Dubock, S., Mattei, M.-G., & Crocker, P. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34089 · Cited by 253
Sialoside Specificity of the Siglec Family Assessed Using Novel Multivalent Probes
Blixt, O., Collins, B. E., van den Nieuwenhof, I. M., Crocker, P. R., & Paulson, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304331200 · Cited by 245
Nicoll, G., Avril, T., Lock, K., Furukawa, K., Bovin, N., & Crocker, P. R. (2003) · European Journal of Immunology · doi:10.1002/eji.200323693 · Cited by 245
Murphy, W. J., Kumar, V, & Bennett, M. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.4.1212 · Cited by 241
Chemical Approaches to Glycobiology
Kiessling, L. L., & Splain, R. A. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.070606.100917 · Cited by 236
Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma
Leonard, J. P., Coleman, M., Ketas, J. C., Chadburn, A., Furman, R., Schuster, M. W., Feldman, E. J., Ashe, M., Schuster, S. J., Wegener, W. A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0294 · Cited by 226
Falco, M., Biassoni, R., Bottino, C., Vitale, M., Sivori, S., Augugliaro, R., Moretta, L., & Moretta, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.793 · Cited by 222
Dennis, J., Waller, C., Timpl, R., & Schirrmacher, V. (1982) · Nature · doi:10.1038/300274a0 · Cited by 216
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
Belisle, J. A., Horibata, S., Jennifer, G. A., Petrie, S., Kapur, A., André, S., Gabius, H.-J., Rancourt, C., Connor, J., Paulson, J. C., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-118 · Cited by 207
Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9
Ikehara, Y., Ikehara, S. K., & Paulson, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403538200 · Cited by 203
Takamiya, R., Ohtsubo, K., Takamatsu, S., Taniguchi, N., & Angata, T. (2013) · Glycobiology · doi:10.1093/glycob/cws139 · Cited by 189
Avril, T., Floyd, H., Lopez, F., Vivier, E., & Crocker, P. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6841 · Cited by 175
Liang, Y.-J., Ding, Y., Levery, S. B., Lobaton, M., Handa, K., & Hakomori, S.-I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302825110 · Cited by 174
Functional Analysis of Human NK Cells by Flow Cytometry
Bryceson, Y. T., Fauriat, C., Nunes, J. M., Wood, S. M., Björkström, N. K., Long, E. O., & Ljunggren, H. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-362-6_23 · Cited by 155
A sulfated carbohydrate epitope inhibits axon regeneration after injury
Brown, J. M., Xia, J., Zhuang, B., Cho, K.-S., Rogers, C. J., Gama, C. I., Rawat, M., Tully, S. E., Uetani, N., Mason, D. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121318109 · Cited by 154
Aalto, K., Autio, A. K., Kiss, E. A., Elima, K., Nymalm, Y., Veres, T. Z., Marttila‐Ichihara, F., Elovaara, H., Saanijoki, T., Crocker, P. R., et al. (2011) · Blood · doi:10.1182/blood-2010-09-311076 · Cited by 144
Collins, B. E., Blixt, O., Han, S.-F., Duong, B., Li, H.-Y., Nathan, J., Bovin, N., & Paulson, J. (2006) · Journal of Immunology · doi:10.4049/jimmunol.177.5.2994 · Cited by 144
Nath, Hartnell, Happerfield, Miles, Burchell, J., Taylor‐Papadimitriou, & Crocker, P. R. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00827.x · Cited by 142
Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation
Courtney, A. H., Puffer, E. B., Pontrello, J. K., Yang, Z., & Kiessling, L. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807207106 · Cited by 128
Ogata, S., Maimonis, P. J., & Itzkowitz, S. H. (1992) · PubMed · Cited by 120
Siglecs as sensors of self in innate and adaptive immune responses
Paulson, J. C., Macauley, M. S., & Kawasaki, N. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06362.x · Cited by 118
Attrill, H. L., Imamura, A., Sharma, R. S., Kiso, M., Crocker, P. R., & van Aalten, D. M. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601714200 · Cited by 105
Hudak, J. E., Yu, H. H., & Bertozzi, C. R. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206023e · Cited by 95
Self-citationKawasaki, Y., Ito, A., Withers, D. A., Taima, T., Kakoi, N., Saito, S., & Arai, Y. (2010) · Glycobiology · doi:10.1093/glycob/cwq116 · Cited by 93
Yogeeswaran, G., Grönberg, A., Hansson, M., et al. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280419 · Cited by 83
Avril, T., North, S. J., Haslam, S. M., Willison, H. J., & Crocker, P. R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005559 · Cited by 81
Investigating Cell Surface Galectin-Mediated Cross-Linking on Glycoengineered Cells
Belardi, B., O’Donoghue, G. P., Smith, A. W., Groves, J. T., & Bertozzi, C. R. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301694s · Cited by 75
Self-citationCohen, M., Elkabets, M., Perlmutter, M., Porgador, A., Voronov, E., Apte, R. N., & Lichtenstein, R. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001635 · Cited by 75
Natural Killer Cells and the Immune Response in Solid Organ Transplantation
van der Touw, W., & Bromberg, J. S. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03086.x · Cited by 60
Rabuka, D., Parthasarathy, R., Lee, G. S., Chen, X., Groves, J. T., & Bertozzi, C. R. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067819i · Cited by 52
Self-citationXenotransplantation: Role of natural immunity
Li, S., Waer, M., & Billiau, A. (2008) · Transplant Immunology · doi:10.1016/j.trim.2008.10.004 · Cited by 50
Godal, R., Keilholz, U., Uharek, L., Letsch, A., Asemissen, A. M., Busse, A., Na, I., Thiel, E., & Scheibenbogen, C. (2005) · Blood · doi:10.1182/blood-2005-07-2880 · Cited by 40
Triulzi, C., Vertuani, S., Curcio, C., Antognoli, A., Seibt, J., Akusjärvi, G., Wei, W., Cavallo, F., & Kiessling, R. W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0493 · Cited by 27
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Siglec-mediated regulation of immune cell function in disease
Macauley, M. S., Crocker, P. R., & Paulson, J. C. (2014) · Nature Reviews Immunology · doi:10.1038/nri3737 · Cited by 1,122
Small RNAs are modified with N-glycans and displayed on the surface of living cells
Flynn, R. A., Pedram, K., Malaker, S. A., Batista, P. J., Smith, B. A. H., Johnson, A. G., George, B. M., Majzoub, K., Villalta, P. W., Carette, J. E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.023 · Cited by 633
Self-citationHallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
Smith, B. A. H., & Bertozzi, C. R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00093-1 · Cited by 500
Self-citation
Metadata
- Authors
- Hudak, J. E., Canham, S. M., & Bertozzi, C. R.
- Venue
- Nature Chemical Biology
- Published
- 2013-11-24
- Volume
- 10
- Issue
- 1
- Pages
- 69-75
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2144577119
- Cited by
- 485
- References
- 53
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.